- Zeroing in on canine atopic dermatitis
- What makes dogs itch?
- Retrospective evaluation of Apoquel® (oclacitinib) for the treatment of atopic dermatitis. Part 2: monitoring for side effects.
- Apoquel vs. Atopica: a comparison of two medications to control atopic dermatitis in dogs
- Retrospective evaluation of Apoquel® (oclacitinib) for the treatment of 117 dogs with atopic dermatitis. Part 1: control of pruritus (itch).
Learn more about RESPIT
Subscribe to the SkinVet e-Newsletter!
Tag Archives: pet
By Jon Plant, DVM, DACVD Atopica® (cyclosporine) and Apoquel® (oclacitinib) are separate and distinct medications. Both are used for controlling the signs and symptoms of atopic dermatitis (“allergies”) in dogs. They are two of the most effective allergy treatments for … Continue reading
You will soon have a new tool for the management of itchy dogs. This is going to be a must-have app for veterinarians who treat allergic dermatitis. Among the features of this iOS app are: Pet parent grading and recording … Continue reading
By Jon Plant, DVM, DACVD Scratching, biting, chewing, rubbing, and excessive licking can all be signs of itch (pruritus) in dogs. A number of methods have been developed to try to quantify itching, but these are most useful in research … Continue reading
By Jon Plant, DVM, DACVD There is a huge demand for Apoquel®, the new Zoetis (NYSE: ZTS) drug for dogs with atopic dermatitis or “allergic” dermatitis. I predict that Apoquel sales will exceed $1 billion per year for Zoetis after … Continue reading
By Jon Plant, DVM, DACVD Bad news, good news about Apoquel® from Zoetis (NYSE: ZTS). We learned last week that the Apoquel backorder situation is likely to continue throughout 2014 and into the summer of 2015. That is very sad … Continue reading
By Jon Plant, DVM, DACVD How much do we know about Apoquel’s safety? Quite a lot, I would argue. The short-term safety profile, based on the data collected during multiple randomized-controlled trials at recommended doses looks good. In a 28-day … Continue reading
by Jon Plant, DVM, DACVD Two routes of administration may be used for allergen immunotherapy: subcutaneous injection or oromucosal / sublingual. The subcutaneous route has been in use in humans and animals for more than 50 years. After an initial … Continue reading